Complications from Soft-Tissue Augmentation of the Face: A Guide to Understanding, Avoiding, and Managing Periprocedural Issues

Injectable Fillers: Principles and Practice

Volumn , Issue , 2010, Pages 121-139

  Glashofer, Marc D ^a   Cohen, Joel L ^b  

^a Island Dermatology   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Augmentation; Complications; Cosmetic; Filler; Glabella; Granuloma; Hyaluronidase; Necrosis; Sensitivity; Supratrochlear artery

Indexed keywords

EID: 84885446850     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444315004.ch10     Document Type: Chapter

References (54)

1. Physician Practice Survey. American Society for Dermatologic Surgery, Rolling Meadows, Illinois. 2007.
2. Andre P. Evaluation of the safety of a non - animal stabilized hyaluronic acid (NASHA - Q - Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 2004; 18: 422 - 5.
3. Godin MS, Majmundar MV, Chrzanowski DS, Dodson KM. Use of Radiesse in combination with Restylane for facial augmentation. Arch Facial Plast Surg 2006; 8: 92 - 7.
4. Brody HJ, Geronemus R, Farris P. Beauty Versus Medicine: The Nonphysician Practice of Dermatologic Surgery. Dermatol Surg 2003; 29: 319 - 24.
5. Executive Summary Dermal Filler Devices General and Plastic Surgery Devices Panel, Food and Drug Administration. November 2008. ( www.fda.gov/OHRMS/DOCKETS/ac/08/briefing/2008-4391b1-01%20-%20FDA%20Executive%20Summary%20Dermal%20Fillers.pdf )
6. Narins RS, Brandt F, Leyden J, et al. A randomized, double - blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588 - 95.
7. Niamtu J, Smith K, Carruthers J. Pain control in cosmetic facial surgery. In: Dover JS, Alam, M, eds. Procedures in Cosmetic Dermatology. Philadelphia: Saunders Elsevier, 2008: pp. 127 - 41.
8. Bauman, L. Minimizing bruising. Skin Aging 2007; 15 ( 10 ): 48 - 9.
9. Ang - Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2000; 286: 208 - 16.
10. Dinehart SM, Henry L. Dietary supplements: altered coagulation and effects on bruising. Dermatol Surg 2005; 31: 819 - 26.
11. Kumakura S, Yamashita M, Tsurufuji S. Effect of bromelain on kaolin - induced inflammation in rats. Eur J Pharmacol 1988; 150: 295 - 301.
12. Seltzer AP. Minimizing post - operative edema and ecchymosis by the use of an oral enzyme preparation (bromelain). A controlled study of 53 rhinoplasty cases. Eye Ear Nose Throat Mon 1962; 41: 813 - 7.
13. Gylling U, Rintala A, Taipale S, et al. The effect of a proteolytic enzyme combinate (bromelain) on the postoperative edema by oral application. A clinical and experimental study. Acta Chir Scand 1966; 131: 193 - 6.
14. Lyss G, Schmidt TJ, Merfort I, Pahl HL. Helenalin, an anti - inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF - κ B. Biol Chem 1997; 378: 951 - 61.
15. Schroder H, Losche W, Strobach H, et al. Helenalin and 11alpha,13 - dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol - dependent pathways. Thromb Res 1990; 57: 839 - 45.
16. Narins RS, Jewell M, Rubin M, et al. Clinical conference: management of rare events following dermal fillers - focal necrosis and angry red bumps. Dermatol Surg 2006; 32: 426 - 34.
17. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31: 893 - 7.
18. Hirsch RJ, Cohen JL. Surgical insights: challenge: correcting superficially placed hyaluronic acid. Skin Aging 2007; 15: 36 - 8.
19. Sculptra. Prescribing information. Bridgewater, NJ: Dermik Laboratories, 2006.
20. Werschler P. The Cosmetic Study Investigator Group. Efficacy of injectable poly - L - lactic acid versus human collagen for the correction of nasolabial fold wrinkles. Presented at the American Society for Dermatologic Surgery. October 28, 2006; Palm Desert, CA, Abstract CS359.
21. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly - L - lactic acid for the treatment of HIV - associated facial lipoatrophy. J Am Acad Dermatol 2005; 52: 233 - 9.
22. Engelhard P, Knies M. Safety and efficacy of New - Fill ® (polylactic acid) in the treatment of HIV - associated lipoatrophy of the face (HALF). XIV International AIDS Conference; 2002 Jul 7 - 12; Barcelona, Spain.
23. Stewart D, Gladstone H, Mooney M, et al. Visible papules after periorbital injection of poly - L - lactic acid. Ophthal Plast Reconstr Surg 2007; 23: 298 - 301.
24. Narins, RS. Minimizing adverse events associated with poly - L - lactic acid injection. Dermatol Surg 2008; 34 ( suppl 1 ): S100 - 4.
25. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10 - year history, indications, techniques, and complications. Dermatol Surg 2003; 29: 573 - 87.
26. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg 2006; 25: 132 - 7.
27. Donofrio L. Technique of periorbital lipoaugmentation. Dermatol Surg 2003; 29: 92 - 98.
28. Fern á ndez - Ace ñ ero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 2003; 29: 1225 - 6.
29. Beljaards RC, de Roos K - P, Bruins FG. NewFill for skin augmentation: A new filler or failure? Dermatol Surg 2005; 31: 772 - 6.
30. Newburger AE. Cosmetic medical devices and their FDA regulation. Arch Dermatol 2006; 142: 225 - 8.
31. Christensen, L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33 ( suppl 2 ): S168 - 75.
32. Baumann LS, Halem ML. Lip silicone granulomatous foreign body reaction treated with aldara (imiquimod 5%). Dermatol Surg 2003; 29: 429 - 32.
33. Odunze M, Cohn A, Few JW. Restylane and people of color. Plast Reconstr Surg 2007; 120: 2011 - 16.
34. Obagi S. Autologous fat augmentation and periorbital laser resurfacing complicated by abscess formation. Am J Cosmet Surg 2003; 20: 155 - 7.
35. Klein AW. Injectable bovine collagen. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and techniques. New York: Marcel Dekker, 1998: pp. 269 - 91.
36. Narins RS, Monheit G. Editorial Comment. Dermatol Surg 2008; 34: S1.
37. Christensen L, Breiting V, Vuust J, Hogdall E. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006; 28: 464 - 71.
38. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31: 1616 - 25.
39. Zarini E, Supino R, Pratesi G, et al. Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg 2004; 15: 934 - 42.
40. Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003; 29: 971 - 3.
41. Shoshani D, Markovitz E, Cohen Y, et al. Skin test hypersensitivity study of a cross - linked, porcine collagen implant for aesthetic surgery. Dermatol Surg 2007; 33: S152 - 8.
42. Narins R, Monheit G. Evolence - a new collagen filler. Presentation at the World Congress of Dermatology, Buenos Aires, October 2, 2007.
43. Stolman LP. To the editor: human collagen reactions. Dermatol Surg 2005; 31: 1634.
44. Leonhardt JM, Lawrence N, Narins RS. Angioedema acute hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg 2005; 31: 577 - 9.
45. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28: 491 - 4.
46. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006; 32: 276 - 81.
47. Hanke CW, Hingley R, Jolivette DM, et al. Abscess formation and local necrosis after treatment with Zyderm ® or Zyplast ® collagen implant. J Am Acad Dermatol 1991; 25: 319 - 26.
48. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007; 33: 357 - 60.
49. Hirsch RJ, Lupo M, Cohen JL, Duffy D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol 2007; 6: 325 - 8.
50. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002; 146: 928 - 9.
51. Hanke CW. Adverse reactions to bovine collagen. In: Klein A, ed. Augmentation in Clinical Practice: Procedures and techniques. New York: Marcel Dekker, 1998: p. 145.
52. Dreizen NG, Framm L. Sudden unilateral visual loss after autologous fat injection into the glabellar area. Am J Opthalmol 1989; 107: 85 - 87.
53. Feinendegen D, Baumgartner R, Schroth G, Mattle H, Tschopp H. Middle cerebral artery occlusion and ocular fat embolism after autologous fat injection in the face. J Neurol 2009; 245: 53 - 4.
54. Yoon SS, Chang DI, Chung KC. Acute fatal stroke immediately following autologous fat injection into the face. Neurology 2003; 61: 1151 - 2.